Specialized Health Products International Inc. (fka SHPI)

[MikeDDKing]

I listened to the SHPI Q3 conference call again. Here are some quotes and notes from the call:

1. "...we expect Q4 operating expenses to remain at the same level or move lower compared with the third quarter."

2. "...and have already begun to implement some cost reductions in the fourth quarter."

3. "...we expect to begin shipping two new manufactured product lines over the next six months."

4. They have stockholder approval for a R/S of up to 1 for 10 which would enable them to get on the Nasdaq Capital Market. The only requirement they are missing right now for the Nasdaq Capital Market is the minimum stock price. They consider the R/S on a continual basis but they don't feel the timing is quite right. They would like to be in the mid to low end of the range of R/S range (e.g. 1 for 5 or lower) before executing on the R/S. My interpretation of what they stated is that they will not do a R/S at least until after Q4 results are out if at all.

5. "We anticipate holding gross margin roughly where it is today."

6. "...Europe is a high potential market and the Huber needle market in Europe is about the same size of that in the U.S." "...and that the majority of 2008 will benefit from growth in Europe."

Mike